Literature DB >> 19089818

The biochemistry of drug metabolism--an introduction: part 6. Inter-individual factors affecting drug metabolism.

Stefanie D Krämer1, Bernard Testa.   

Abstract

This review is part of a series of review articles on the metabolism of drugs and other xenobiotics published in Chemistry & Biodiversity. After a thorough discussion of metabolic reactions and their enzymes, this article focuses on genetically determined differences in drug and xenobiotic metabolism. After a short introduction on the causes for genetic differences, the first focus is on species differences in drug and xenobiotic metabolism. A major chapter is then dedicated to clinically relevant genetic polymorphisms in human drug metabolism and resultant ethnic differences. The last two chapters deal with sex-dependent differences in drug metabolism and personalized pharmacotherapy related to inter-individual differences in drug metabolism.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19089818     DOI: 10.1002/cbdv.200890214

Source DB:  PubMed          Journal:  Chem Biodivers        ISSN: 1612-1872            Impact factor:   2.408


  6 in total

Review 1.  Xanthines as adenosine receptor antagonists.

Authors:  Christa E Müller; Kenneth A Jacobson
Journal:  Handb Exp Pharmacol       Date:  2011

2.  Tenofovir disoproxil fumarate: toxicity, toxicokinetics, and toxicogenomics analysis after 13 weeks of oral administration in mice.

Authors:  Hanna H Ng; Howard Stock; Linda Rausch; Deborah Bunin; Abraham Wang; Shirley Brill; Jason Gow; Jon C Mirsalis
Journal:  Int J Toxicol       Date:  2015-01-07       Impact factor: 2.032

3.  Homology modeling and metabolism prediction of human carboxylesterase-2 using docking analyses by GriDock: a parallelized tool based on AutoDock 4.0.

Authors:  Giulio Vistoli; Alessandro Pedretti; Angelica Mazzolari; Bernard Testa
Journal:  J Comput Aided Mol Des       Date:  2010-07-11       Impact factor: 3.686

4.  Preclinical evaluation and test-retest studies of [(18)F]PSS232, a novel radioligand for targeting metabotropic glutamate receptor 5 (mGlu5).

Authors:  Selena Milicevic Sephton; Adrienne Müller Herde; Linjing Mu; Claudia Keller; Sonja Rüdisühli; Yves Auberson; Roger Schibli; Stefanie D Krämer; Simon M Ametamey
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-08-20       Impact factor: 9.236

5.  Synthesis, radiolabelling and in vitro and in vivo evaluation of a novel fluorinated ABP688 derivative for the PET imaging of metabotropic glutamate receptor subtype 5.

Authors:  Selena Milicevic Sephton; Patrick Dennler; Dominique S Leutwiler; Linjing Mu; Cindy A Wanger-Baumann; Roger Schibli; Stefanie D Krämer; Simon M Ametamey
Journal:  Am J Nucl Med Mol Imaging       Date:  2011-12-10

6.  New perspectives on chinese herbal medicine (zhong-yao) research and development.

Authors:  Si-Yuan Pan; Si-Bao Chen; Hong-Guang Dong; Zhi-Ling Yu; Ji-Cui Dong; Zhi-Xian Long; Wang-Fun Fong; Yi-Fan Han; Kam-Ming Ko
Journal:  Evid Based Complement Alternat Med       Date:  2011-03-10       Impact factor: 2.629

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.